Marianne Hallupp

Camperdown, NSW 2006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.

Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.

Journal: Human molecular genetics

Published: August 08, 2025

Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.

Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.

Journal: Scientific reports

Published: April 06, 2021

Reply: CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort.

Reply: CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort.

Journal: Brain : a journal of neurology

Published: July 16, 2020

Are mutations in MAPT associated with GGT type III?

Are mutations in MAPT associated with GGT type III?

Journal: Neuropathology and applied neurobiology

Published: August 13, 2019

CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.

CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: August 01, 2019

Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.

Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.

Journal: Journal of Alzheimer's disease : JAD

Published: April 05, 2018

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Journal: Brain : a journal of neurology

Published: August 01, 2017

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.

Journal: PloS one

Published: February 03, 2016

Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?

Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?

Journal: Brain : a journal of neurology

Published: May 09, 2015

Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.

Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.

Journal: Current Alzheimer research

Published: November 17, 2014

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 09, 2013

Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.

Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.

Journal: Disease models & mechanisms

Published: June 27, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026